Financhill
Back

Halozyme Therapeutics Stock Price Chart

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
72

HALO
Halozyme Therapeutics

Last Price:
57.97
Seasonality Move:
16.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing slight buying pressure.

Halozyme Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 52.06 Buy
20-day SMA: 52.41 Buy
50-day SMA: 57.09 Buy
200-day SMA: 47.88 Buy
8-day EMA: 53.6 Buy
20-day EMA: 53.47 Buy
50-day EMA: 54.91 Buy
200-day EMA: 50.09 Buy

Halozyme Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 64.31 Buy
Chaikin Money Flow: 522918 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.37 - 56.81) Buy
Bollinger Bands (100): (51.47 - 59.79) Buy

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Halozyme Therapeutics Stock

Is Halozyme Therapeutics Stock a Buy?

HALO Technical Analysis vs Fundamental Analysis

Buy
72
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy or a Sell?

Halozyme Therapeutics Stock Info

Market Cap:
7.44B
Price in USD:
58.46
Share Volume:
1.89M

Halozyme Therapeutics 52-Week Range

52-Week High:
65.53
52-Week Low:
33.15
Buy
72
Halozyme Therapeutics (HALO) is a Buy

Halozyme Therapeutics Share Price Forecast

Is Halozyme Therapeutics Stock a Buy?

Fundamental Analysis of Halozyme Therapeutics

Is Halozyme Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.66 per share.

Technical Analysis of Halozyme Therapeutics

Should I short Halozyme Therapeutics stock?

* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.